Viewing data from:

CHLOROTHIAZIDE SODIUM

ANDA

CHLOROTHIAZIDE SODIUM | A202561 | AMERICAN REGENT INC

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Chlorothiazide Sodium (2023)

Total Spending

$15K

Total Claims

243

Beneficiaries

123

ASP Price

—

HCPCS: J1205 — Injection, chlorothiazide sodium, per 500 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

WOCKHARDT LTDCHLOROTHIAZIDE SODIUM

DMF 226022009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 500MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Apr 22, 2013

No patent or exclusivity listings for this strength.